Erratum: Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history (American Journal of Obstetrics and Gynecology (2017) 217(5) (585.e1–585.e5) (S0002937817309298) (10.1016/j.ajog.2017.07.038));Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

American Journal of Obstetrics and Gynecology

Volumn 217, Issue 5, 2017, Pages 585.e1-585.e5

  Poon, Liona C ^a,e   Wright, David ^f   Rolnik, Daniel L ^a   Syngelaki, Argyro ^a   Delgado, Juan Luis ^g   Tsokaki, Theodora ^a,b   Leipold, Gergo ^a,c   Akolekar, Ranjit ^a,h   Shearing, Siobhan ⁱ   De Stefani, Luciana ^a,d   Jani, Jacques C ^j   Plasencia, Walter ^k   Evangelinakis, Nikolaos ^l   Gonzalez Vanegas, Otilia ^m   Persico, Nicola ⁿ   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f UNIVERSITY OF EXETER   (United Kingdom)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^h MEDWAY MARITIME HOSPITAL   (United Kingdom)

ⁱ SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^j BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^k Grupo Hospiten   (Spain)

^l NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^m HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

ⁿ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

more..

Author keywords

aspirin; ASPRE trial; chronic hypertension; first trimester screening; mean arterial blood pressure; placental growth factor; preeclampsia; pregnancy associated plasma protein A; uterine artery Doppler

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTITHROMBOCYTIC AGENT;

ADULT; AFRICAN CARIBBEAN; ARTICLE; BODY MASS; CAUCASIAN; CONCEPTION; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICATION COMPLIANCE; MULTIPARA; NULLIPARA; PATIENT COMPLIANCE; PREECLAMPSIA; PRETERM PREECLAMPSIA; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SMOKING; ALGORITHM; ANAMNESIS; EVIDENCE BASED MEDICINE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; INFERTILITY THERAPY; OBESITY; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; REPRODUCTIVE HISTORY; RISK ASSESSMENT; STATISTICAL MODEL; UTILIZATION;

ADULT; ALGORITHMS; ASPIRIN; BODY MASS INDEX; EVIDENCE-BASED MEDICINE; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MATERNAL AGE; MEDICAL HISTORY TAKING; ODDS RATIO; OVERWEIGHT; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; REPRODUCTIVE HISTORY; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK ASSESSMENT; SMOKING;

EID: 85029488844     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2018.01.002     Document Type: Erratum

References (27)

1. Rolnik, D.L., Wright, D., Poon, L.C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377 (2017), 613–622.
2. Akolekar, R., Syngelaki, A., Poon, L., Wright, D., Nicolaides, K.H., Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 33 (2013), 8–15.
3. Wright, D., Syngelaki, A., Akolekar, R., Poon, L.C., Nicolaides, K.H., Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol 213 (2015), 62.e1–62.e10.
4. Poon, L.C., Zymeri, N.A., Zamprakou, A., Syngelaki, A., Nicolaides, K.H., Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation. Fetal Diagn Ther 31 (2012), 42–48.
5. Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., Nicolaides, K.H., Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30 (2007), 742–749.
6. Brown, M.A., Lindheimer, M.D., de Swiet, M., Van Assche, A., Moutquin, J.M., The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20 (2001), IX–XIV.
7. R Development Core Team. R: a language and environment for statistical computing. Available at: http://www.R-project.org/. Accessed July 17, 2017.
8. Wright, D., Poon, L.C., Rolnik, D.L., et al. ASPRE trial: influence of adherence on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol, 2017 Sep 6 pii: S0002-9378(17)31097-9. http://dx.doi.org/10.1016/j.ajog.2017.08.110. [Epub ahead of print].
9. Nicolaides, K.H., Turning the pyramid of prenatal care. Fetal Diagn Ther 29 (2011), 183–196.
10. Roberge, S., Nicolaides, K.H., Demers, S., Villa, P., Bujold, E., Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 41 (2013), 491–499.
11. Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., Bujold, E., The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 216 (2017), 110–120.e1-6.
12. Meher, S., Duley, L., Hunter, K., Askie, L., Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol 216 (2017), 121–128.
13. Tong, S., Mol, B.W., Walker, S.P., Preventing preeclampsia with aspirin: does dose or timing matter?. Am J Obstet Gynecol 216 (2017), 95–97.
14. European Medicines Agency. Guideline on the investigation of subgroups in confirmatory clinical trials EMA/CHMP/539146/2013. London, UK;2014:1-20.
15. Askie, L.M., Duley, L., Henderson-Smart, D.J., Stewart, L.A., Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007), 1791–1798.
16. Panaitescu, A.M., Syngelaki, A., Prodan, N., Akolekar, R., Nicolaides, K.H., Chronic hypertension and adverse pregnancy outcomes: a cohort study. Ultrasound Obstet Gynecol 50 (2017), 228–235.
17. Brosens, I., Pijnenborg, R., Vercruysse, L., Romero, R., The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 204 (2011), 193–201.
18. Romero, R., Lockwood, C., Oyarzun, E., Hobbins, J.C., Toxemia: new concepts in an old disease. Semin Perinatol 12 (1988), 302–323.
19. Roberts, J.M., Taylor, R.N., Musci, T.J., Rodgers, G.M., Hubel, C.A., Mclaughlin, M.K., Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989), 1200–1204.
20. Redman, C.W., Sacks, G.P., Sargent, I.L., Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 80 (1999), 499–506.
21. Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., Romero, R., Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10 (2014), 466–480.
22. Brandes, R.P., Endothelial dysfunction and hypertension. Hypertension 64 (2014), 924–928.
23. Harrison, D.G., Guzik, T.J., Lob, H.E., et al. Inflammation, immunity, and hypertension. Hypertension 57 (2011), 132–140.
24. Roberts, J.M., Hubel, C.A., The two stage model of preeclampsia: variations on the theme. Placenta 30 (2009), S32–S37.
25. Sacks, G.P., Studena, K., Sargent, I.L., Redman, C.W.G., Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998), 80–86.
26. Morris, J.M., Gopaul, N.K., Endresen, M.J.R., et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 105 (1998), 1195–1199.
27. Panaitescu, A.M., Akolekar, R., Kametas, N., Syngelaki, A., Nicolaides, K.H., Impaired placentation in women with chronic hypertension that develop preeclampsia. Ultrasound Obstet Gynecol, 2017 May 4, 10.1002/uog.17517 [Epub ahead of print].